EN DE

DuPont de Nemours, Inc (DD) Fair Value & Analysis

Basic Materials · US · Market cap $18.3B

DD DuPont de Nemours, Inc logo DuPont de Nemours, Inc DD · US
Price$144.10
Fair Value$142.24
Upside-1.3%
Quality52/100
Watch DuPont de Nemours, Inc for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Loss-making · -0.4% net margin
Low debt · generates free cash flow
2.73% dividend yield
Trails peers (5/15)
Narrow moat 35/100
Evidence: High Range $97.66 – $186.84 Share as image

Fair value as of: Aug 13, 2026

From 15 valuation models · updated today

Fair value updated Aug 13, 2026, revised from $71.12 to $142.24 (+100.0%) since Aug 6, 2026. Share price +7.4% over the past month.

A solid business, currently priced close to our fair value.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • A fairly wide model range ($97.66 to $186.84) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$153.36 $58.15 Fair Value $142.24 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range $58.15 – $153.36 · fair‑value band $97.66 – $186.84 · the $144.10 price screens above the $142.24 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

DuPont de Nemours, Inc (DD) currently trades at $144.10, while our model-based Fair Value estimate is $142.24, implying the stock looks roughly 1.3% fairly valued today. The Quality Score stands at 52/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, DuPont de Nemours, Inc generated revenue of $6.9B at a net margin of -0.4%. Revenue grew 4.3% year over year. It earns a return on equity of 0.9%. Net debt stands at $2.4B. Fundamentals as of Aug 13, 2026

Our scenario range runs from $97.66 (bear case) to $186.84 (bull case); at $144.10, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Basic Materials peers we cover trades at -68% fair-value upside, at -1%, DD screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF $63.67 $93.26 $143.89 80
Rev-Margin DCF $42.33 $68.17 $100.22 74
ROIC Compounder $35.86 $44.77 $52.57 72
All 15 models by family
DCF Models
FCF DCF $60.05 $90.55 $147.02 38
5Y Revenue Exit $42.33 $66.34 $101.18 39
5Y EBITDA Exit $56.34 $90.61 $136.02 41
10Y Revenue Exit $47.28 $65.82 $85.36 36
10Y EBITDA Exit $57.19 $80.83 $105.81 37
Earnings-Based
EPV $35.86 $44.77 $52.57 59
Dividend Discount
Gordon GGM $40.60 $44.44 $50.29 70
DDM Multi-Stage $40.60 $50.94 $65.43 61
Multiples
EV/EBIT $49.27 $71.57 $93.86 53
EV/EBITDA $66.11 $94.01 $121.91 54
EV/Revenue $35.66 $58.48 $81.31 43
Asset-Based
NCAV (Graham) $51.54 $69.07 $103.09 50
Growth DCF
Growth DCF $63.67 $93.26 $143.89 80
Rev-Margin DCF $42.33 $68.17 $100.22 74
Economic Profit
ROIC Compounder $35.86 $44.77 $52.57 72

Widest divergence: DCF Models ($80.83) versus Dividend Discount ($44.44). Highest evidence: Growth DCF (80).

Notify me when DD reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $6.9B
Revenue growth (YoY) +4.3%
Net margin -0.4%
Return on equity 0.9%
Free cash flow $1.1B FY2025
P/E ratio 126.4
More key figures
Operating margin 13.8%
EPS (TTM) $1.14
Dividend yield 2.7%
EPS growth (YoY) -66.9%
Net debt $2.4B FY2025

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 52/100

Of which business quality 50 · Market factors (momentum, volatility) 66

Profitability 8
Margins and returns on capital today
Quality Growth 15
Are margins and returns improving?
Cashflow 71
Earnings quality: real cash, not paper profit
Fin. Strength 43
Balance sheet, leverage, solvency risk
Investment 95
Disciplined investing over empire-building
Low Volatility 61
Calm price path (market factor)
Momentum 56
Price trend over the last 3–12 months (market factor)
52W Momentum 91
Distance to the 52-week high (market factor)
Net Issuance 92
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials.

Full company description

DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors. It also offers AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules. In addition, the company offers engineered products and integrated solutions for the non-residential, residential, and repair-and-remodel construction markets, includes TYVEK house wrap, STYROFOAM insulation, and CORIAN solid surface. Further, it engages in the design and production of engineered components, systems, and process solutions used in OEM and operational applications, such as automotive, aerospace, printing, and packaging. Additionally, the company offers Vespel shapes and parts, MOLYKOTE specialty lubricants, BETAFORCE and BETASEAL structural adhesives, and Cyrel flexographic printing plates. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. was incorporated in 2015 and is headquartered in Wilmington, Delaware.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

DuPont de Nemours, Inc reported revenue of $6.8B in FY2025 versus $12.6B in FY2021, a compound −14.1%/yr. Reported net income was −$779M in FY2025.

Growth Quality 23/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
$6.8B
Latest YoY
−44.7%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−19.3%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−13.7%
Avg. growth/yr (40Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−1.3%
Revenue −14.1%/yr
FY21 $12.6B
FY22 $13.0B
FY23 $12.1B
FY24 $12.4B
FY25 $6.8B
Net income
FY21 $6.5B
FY22 $5.9B
FY23 $423M
FY24 $703M
FY25 −$779M
Character of growth · EPS growth decomposed (2014-2025) −24.0 % p.a.
Revenue per share −16.6 pp

of which total revenue −15.6 pp · buybacks/dilution −1.0 pp

EBIT margin +2.9 pp
Tax rate −1.0 pp
Residual (interest, one-offs) −9.2 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

Watch DD: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "DuPont de Nemours, Inc Fair Value". https://www.fairvalue-calculator.com/stock/DD

Recent news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

Specialty Chemicals · 666 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 52 · Below median
Fair Value upside −1% · Above median
Return on equity (TTM) 1% · Below median
Return on assets 2% · Below median
Net margin (TTM) -0% · Bottom 25%
Operating margin (TTM) 14% · Top 25%
Revenue growth 4% · Above median
Dividend yield (TTM) 2.7% · Above median
Debt / equity 0.23× · Higher than median

Valuation Multiples vs Specialty Chemicals median · lower = cheaper

P/E (TTM) 126.4× · Pricier than 75% of peers
P/B 1.31× · Cheaper than median
P/S (TTM) 2.64× · Pricier than median
P/FCF 16.9× · Pricier than 75% of peers
EV/EBITDA 13.3× · Pricier than median
PEG 1.72× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 32 · sector 0
FUTURE 22 · sector 18
PAST 4 · sector 23
HEALTH 89 · sector 95
DIVIDEND 55 · sector 25

Insider activity: 45/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
Linde plc LIN $479.43 $222.03 -54%
Wanhua Chemical Group 600309 ¥75.06 ¥68.03 -9%
Novozymes A/S NSISB kr 416.10 kr 170.02 -59%
Asian Paints Limited ASIANPAINT ₹2,756 ₹664.51 -76%
Solar Industries India Limited SOLARINDS ₹18,730 ₹2,793 -85%
Pidilite Industries Limited PIDILITIND ₹1,702 ₹351.84 -79%
PT Chandra Asri Pacific Tbk TPIA 2,160 IDR 2,322 IDR +8%
Berger Paints India Limited BERGEPAINT ₹559.80 ₹154.46 -72%
Gujarat Fluorochemicals Limited FLUOROCHEM ₹4,566 ₹836.47 -82%
Himadri Speciality Chemical Limited HSCL ₹778.15 ₹248.63 -68%

Compare DuPont de Nemours, Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is DuPont de Nemours, Inc (DD) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of $142.24 versus a price of $144.10, about −1% (fairly valued).
What is the fair value of DD?
Our model-based fair value for DuPont de Nemours, Inc is $142.24 (as of Aug 13, 2026), built from audited fundamentals. The current price is $144.10.
What is the quality score of DD?
DuPont de Nemours, Inc has a Quality Score of 52/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of DuPont de Nemours, Inc (DD)?
DuPont de Nemours, Inc reported trailing-twelve-month revenue of about $6.9B (latest available figure, as of Aug 13, 2026).
What is the net profit margin of DD?
The net profit margin of DuPont de Nemours, Inc is about -0.4%, meaning it is currently running at a net loss. Based on the latest reported figures.
Does DuPont de Nemours, Inc pay a dividend?
DuPont de Nemours, Inc currently shows a dividend yield of about 2.54% relative to its recent price (as of Aug 13, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track DuPont de Nemours, Inc and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.